Buch, Englisch, 416 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 974 g
Reihe: Basic and Clinical Oncology
Buch, Englisch, 416 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 974 g
Reihe: Basic and Clinical Oncology
ISBN: 978-0-8247-9295-4
Verlag: CRC Press
This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies.
Zielgruppe
Professional and Professional Reference
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Nuklearmedizin, PET, Radiotherapie
Weitere Infos & Material
Respiratory Cancer
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E. Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal, Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J. Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward, Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D. Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller, Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
